US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
By: theblockbeats.news|2025/08/04 12:41:53
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
US Stock DFDV Announces Increase in Holding of 110,000 SOL, Bringing Total Holdings to 1,293,000 SOLThe Ether Machine has announced an increase in holdings of 10,605 ETH, bringing the total holdings to 345,362 ETH.
You may also like
Share
Gainers
Community
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Services:support@weex.com